Results 201 to 210 of about 53,487 (288)
ABSTRACT Severe obesity is associated with an increased cardiovascular risk. Metabolic‐bariatric surgery (MBS) can reduce the risk of cardiovascular events and mortality, potentially depending on weight loss composition. This study assessed the association between post‐MBS weight loss composition and major adverse cardiovascular events (MACE) and all ...
Malou A. H. Nuijten +8 more
wiley +1 more source
Renal response to seven days of lower body positive pressure in the squirrel monkey [PDF]
As a ground-based model for weightlessness, the response of the chair-trained squirrel monkey to lower body positive pressure (LBPP) was evaluated in a length of study similar to a typical Space Shuttle mission (7 days).
Churchill, Susanne +3 more
core +1 more source
Abstract Aims Survodutide is an investigational glucagon receptor/glucagon‐like peptide‐1 receptor dual agonist that has shown promise for treating obesity and its complications in Phase 2 trials. Two double‐blind, randomized, global Phase 3 trials are designed to assess the efficacy and safety of survodutide for treatment of obesity—SYNCHRONIZE™‐1 in ...
Sean Wharton +9 more
wiley +1 more source
Proteins associated with rehospitalization, mortality and diuretic resistance in acutely decompensated heart failure. [PDF]
Hubbell KT +8 more
europepmc +1 more source
Abstract Aim To investigate ethnic differences in the comparative effectiveness of sulfonylureas (SU), dipeptidyl peptidase‐4 inhibitors (DPP4i) and sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) on cardiovascular outcomes. Materials and Methods We identified adults with type 2 diabetes in UK electronic health records initiating SU, DPP4i or SGLT2i
Mia Harley +7 more
wiley +1 more source
Abstract Objective This study provides real‐world evidence on the comparative effectiveness of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) regarding the risk of incident dementia in adults with type 2 diabetes mellitus (T2DM).
Filippos Anagnostakis +4 more
wiley +1 more source
Serum Level of pro Brain Type Natriuretic Peptide in Diuretic Resistance and Diuretic Respondent Ascites in Cirrhotic Patients [PDF]
Ehab F. Mostafa +3 more
openalex +1 more source
ABSTRACT A recent survey in the Philippines, PRESYON‐4, showed increasing prevalence of hypertension from 22% in the 1990s to 37% in 2021, of which only 52% were aware of their diagnosis. While rates of treatment and adherence were 68% and 86%, respectively, the rate of BP control was low at 37%. Furthermore, there remained a high degree of unawareness
Deborah Ignacia D. Ona +17 more
wiley +1 more source
A Pragmatic Approach to Acute Cardiorenal Syndrome: Diagnostic Strategies and Targeted Therapies to Overcome Diuretic Resistance. [PDF]
Tran P +6 more
europepmc +1 more source
The Effects of KW‐3902, an Adenosine A1‐Receptor Antagonist, on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure and Renal Impairment or Diuretic Resistance [PDF]
openalex +1 more source

